← Back to Search

Twice per week dialysis for Kidney Failure (D-LITE Trial)

N/A
Waitlist Available
Research Sponsored by Dr. Christine White
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if elderly patients over 70 can have better well-being by reducing the frequency of their treatments. The study aims to see if this change is safe and feasible.

Eligible Conditions
  • Kidney Failure
  • Dialysis
  • Hemodialysis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Loss to trial completion
Percent of weekly post hemodialysis weights that are within 1 kg of prescribed dry weight
Percent of weekly potassium values falling within normal range.
+2 more
Secondary study objectives
Change in Patient's Quality of Life - Using Edmonton Symptom Assessment System (ESAS-R)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Twice per week dialysisExperimental Treatment1 Intervention
Twice-weekly 4 hour dialysis treatment (Monday and Friday or Tuesday and Saturday).
Group II: Thrice per week dialysisActive Control1 Intervention
Standard thrice-weekly 4 hour dialysis treatment (Monday, Wednesday and Friday or Tuesday, Thursday and Staurday)

Find a Location

Who is running the clinical trial?

Dr. Christine WhiteLead Sponsor
Queen's UniversityLead Sponsor
373 Previous Clinical Trials
124,017 Total Patients Enrolled

Media Library

Twice per week dialysis Clinical Trial Eligibility Overview. Trial Name: NCT03787719 — N/A
Kidney Failure Clinical Trial 2023: Twice per week dialysis Highlights & Side Effects. Trial Name: NCT03787719 — N/A
Kidney Failure Research Study Groups: Twice per week dialysis, Thrice per week dialysis
Twice per week dialysis 2023 Treatment Timeline for Medical Study. Trial Name: NCT03787719 — N/A
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top